A systematic review and meta-analysis of the effect of intravitreal VEGF inhibitors on cardiorenal outcomes

BACKGROUND: Vascular endothelial growth factor inhibitors (VEGFis) have transformed the treatment of many retinal diseases, including diabetic maculopathy. Increasing evidence supports systemic absorption of intravitreal VEGFi and development of significant cardiorenal side effects. METHODS: We cond...

Descripción completa

Detalles Bibliográficos
Autores principales: Lees, Jennifer S, Dobbin, Stephen J H, Elyan, Benjamin M P, Gilmour, David F, Tomlinson, Laurie P, Lang, Ninian N, Mark, Patrick B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310520/
https://www.ncbi.nlm.nih.gov/pubmed/36318455
http://dx.doi.org/10.1093/ndt/gfac305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310520/
https://www.ncbi.nlm.nih.gov/pubmed/36318455
http://dx.doi.org/10.1093/ndt/gfac305

Ejemplares similares